MYD88 mutations can be used to identify malignant pleural effusions in Waldenström macroglobulinaemia

E-ISSN： 1365-2141|180|4|578-581

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.180, Iss.4, 2018-02, pp. : 578-581

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

CXCR4 WHIM‐like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88L265P‐directed survival signalling in Waldenström macroglobulinaemia cells

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 5, 2015-03 ,pp. : 701-707

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of the Effectiveness of Some Pleural Sclerosing Agents Used for Control of Effusions in Malignant Pleural Mesothelioma: A Review of 117 Cases

Respiration, Vol. 67, Iss. 6, 2000-12 ,pp. : 623-629

Karger

Access to resources Recommend Favorite

MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 6, 2015-06 ,pp. : 795-803

John Wiley & Sons Inc

Access to resources Recommend Favorite

MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 2, 2018-02 ,pp. : 187-194

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primum non nocere and Malignant Pleural Effusions

Respiration, Vol. 71, Iss. 6, 2004-12 ,pp. : 549-550

Karger

Access to resources Recommend Favorite